NEW YORK, Nov 7 (Reuters) - Privately held Prometheus Laboratories Inc said on Wednesday it has agreed to acquire exclusive U.S. rights to GlaxoSmithKline's irritable bowel syndrome drug Lotronex.
It looks like Mayo Clinic lost its legal dispute with Prometheus Labs over the patenting of standards for a diagnostic test. This is a deal that went to the Supreme Court about six months ago. It ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback